Relationship of CD8+ T cell noncytotoxic anti-HIV response to CD4+ T cell number in untreated asymptomatic HIV-infected individuals

被引:28
作者
Castelli, JC
Deeks, SG
Shiboski, S
Levy, JA [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA
关键词
D O I
10.1182/blood-2001-11-0078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During chronic HIV infection, asymptomatic individuals demonstrate a strong CD8(+) cell noncytotoxic antiviral response (CNAR). With the onset of symptoms or reduction in CD4(+) cell counts, CNAR decreases. Presently, it is recommended that infected individuals receive antiretroviral therapy if CD4(+) cell counts fall below 350 cells/muL. To determine whether CNAR lends support to this recommendation for initiation of antiretroviral treatment, we examined CNAR in 20 healthy, untreated, HIV-infected men exhibiting a range of CD4(+) cell numbers. Our results indicate that the asymptomatic untreated HIV-infected individuals with less than 300 CD4(+) cells/muL had a significantly lower CNAR than those with higher CD4(+) cell counts. These data on CNAR in untreated, healthy, HIV-infected individuals support the current recommendation for when to initiate antiretroviral therapy. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:4225 / 4227
页数:3
相关论文
共 14 条
  • [1] Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome
    Barker, E
    Mackewicz, CE
    Reyes-Terán, G
    Sato, A
    Stranford, SA
    Fujimura, SH
    Christopherson, C
    Chang, SY
    Levy, JA
    [J]. BLOOD, 1998, 92 (09) : 3105 - 3114
  • [2] CLINICAL-EVALUATION OF BRANCHED DNA SIGNAL AMPLIFICATION FOR QUANTIFYING HIV TYPE-1 IN HUMAN PLASMA
    CAO, YZ
    HO, DD
    TODD, J
    KOKKA, R
    URDEA, M
    LIFSON, JD
    PIATAK, M
    CHEN, S
    HAHN, BH
    SAAG, MS
    SHAW, GM
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (03) : 353 - 361
  • [3] Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel
    Carpenter, CCJ
    Cooper, DA
    Fischl, MA
    Gatell, JM
    Gazzard, BG
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schechter, M
    Schooley, RT
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03): : 381 - 390
  • [4] HIV-1 EXPRESSION IN CHIMPANZEES CAN BE ACTIVATED BY CD8+ CELL DEPLETION OR CMV INFECTION
    CASTRO, BA
    HOMSY, J
    LENNETTE, E
    MURTHY, KK
    EICHBERG, JW
    LEVY, JA
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 65 (03): : 227 - 233
  • [5] GOMEZ AM, 1994, CLIN EXP IMMUNOL, V97, P68
  • [6] CHARACTERIZATION OF THE AIDS-ASSOCIATED RETROVIRUS REVERSE-TRANSCRIPTASE AND OPTIMAL CONDITIONS FOR ITS DETECTION IN VIRIONS
    HOFFMAN, AD
    BANAPOUR, B
    LEVY, JA
    [J]. VIROLOGY, 1985, 147 (02) : 326 - 335
  • [7] AN ACTIVATED CD8+ T-CELL PHENOTYPE CORRELATES WITH ANTI-HIV ACTIVITY AND ASYMPTOMATIC CLINICAL STATUS
    LANDAY, AL
    MACKEWICZ, CE
    LEVY, JA
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 69 (01): : 106 - 116
  • [8] Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8(+) T cells
    Levy, JA
    Mackewicz, CE
    Barker, E
    [J]. IMMUNOLOGY TODAY, 1996, 17 (05): : 217 - 224
  • [9] RECOVERY OF AIDS-ASSOCIATED RETROVIRUSES FROM PATIENTS WITH AIDS OR AIDS-RELATED CONDITIONS AND FROM CLINICALLY HEALTHY-INDIVIDUALS
    LEVY, JA
    SHIMABUKURO, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (04) : 734 - 738
  • [10] MACKEWICZ CE, 1994, LANCET, V344, P1671, DOI 10.1016/S0140-6736(94)90459-6